Susquehanna International Group, LLP Albireo Pharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $99,055 - $130,790	-5,500 Reduced 20.68%	21,100 $455,000
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $791,520 - $1.28 Million	-48,500 Reduced 64.58%	26,600 $515,000
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $984,474 - $1.98 Million	-53,100 Reduced 41.42%	75,100 $1.49 Million
Q1 2022 May 16, 2022	BUY	$23.94 - $33.74 $2.57 Million - $3.63 Million	107,500 Added 519.32%	128,200 $3.82 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $1.15 Million - $1.69 Million	-54,100 Reduced 72.33%	20,700 $482,000
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $938,448 - $1.23 Million	34,300 Added 84.69%	74,800 $2.33 Million
Q2 2021 Aug 11, 2021	BUY	$28.9 - $36.87 $482,630 - $615,729	16,700 Added 70.17%	40,500 $1.43 Million
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $313,894 - $419,930	9,800 Added 70.0%	23,800 $839,000
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $1.63 Million - $2.18 Million	-51,700 Reduced 78.69%	14,000 $525,000
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $825,564 - $1.48 Million	35,600 Added 118.27%	65,700 $2.19 Million
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $54,834 - $110,704	-3,700 Reduced 10.95%	30,100 $797,000
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $394,446 - $920,374	33,800 New	33,800 $553,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.